As CYP17A1 converts pregnanolone to DHEA and CYP19A1, which converts androgen to estrogen, this enzyme has been implicated in the development of TMZ resistance in GBM [48–50, 60]. The gene discussed is CYP17A1; the disease is glioblastoma.